{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:42:31Z","timestamp":1777502551709,"version":"3.51.4"},"reference-count":143,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine (Lond.)"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.2217\/nnm-2019-0443","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T08:25:09Z","timestamp":1588753509000},"page":"1239-1261","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":132,"title":["Current Advances in The Development of Novel Polymeric Nanoparticles for The Treatment of Neurodegenerative Diseases"],"prefix":"10.1080","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9567-4283","authenticated-orcid":false,"given":"Amanda","family":"Cano","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Pharmaceutical Technology & Physical Chemistry, Faculty of Pharmacy & Food Sciences, University of Barcelona, Barcelona, Spain"},{"name":"Institute of Nanoscience & Nanotechnology (IN2UB), Barcelona, Spain"},{"name":"Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"S\u00e1nchez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Pharmaceutical Technology & Physical Chemistry, Faculty of Pharmacy & Food Sciences, University of Barcelona, Barcelona, Spain"},{"name":"Institute of Nanoscience & Nanotechnology (IN2UB), Barcelona, Spain"},{"name":"Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miren","family":"Ettcheto","sequence":"additional","affiliation":[{"name":"Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Madrid, Spain"},{"name":"Department of Pharmacology, Toxicology & Therapeutic Chemistry, Faculty of Pharmacy & Food Sciences, University of Barcelona, Barcelona, Spain"},{"name":"Unit of Biochemistry & Pharmacology, Faculty of Medicine & Health Sciences, University of Rovira i Virgili, Reus (Tarragona), Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"L\u00f3pez-Machado","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Pharmaceutical Technology & Physical Chemistry, Faculty of Pharmacy & Food Sciences, University of Barcelona, Barcelona, Spain"},{"name":"Institute of Nanoscience & Nanotechnology (IN2UB), Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Espina","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Pharmaceutical Technology & Physical Chemistry, Faculty of Pharmacy & Food Sciences, University of Barcelona, Barcelona, Spain"},{"name":"Institute of Nanoscience & Nanotechnology (IN2UB), Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana B","family":"Souto","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal"},{"name":"CEB, Centre of Biological Engineering, University of Minho, Campus de Gualtar 4710-057, Braga, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Galindo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Pharmaceutical Technology & Physical Chemistry, Faculty of Pharmacy & Food Sciences, University of Barcelona, Barcelona, Spain"},{"name":"Institute of Nanoscience & Nanotechnology (IN2UB), Barcelona, Spain"},{"name":"Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Madrid, Spain"},{"name":"Unit of Synthesis & Biomedical Applications of Peptides, Department of Biomedical Chemistry, Institute for Advanced Chemistry of Catalonia, Consejo Superior de Investigaciones Cient\u00edficas (IQAC-CSIC), Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Camins","sequence":"additional","affiliation":[{"name":"Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Madrid, Spain"},{"name":"Department of Pharmacology, Toxicology & Therapeutic Chemistry, Faculty of Pharmacy & Food Sciences, University of Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Pharmaceutical Technology & Physical Chemistry, Faculty of Pharmacy & Food Sciences, University of Barcelona, Barcelona, Spain"},{"name":"Institute of Nanoscience & Nanotechnology (IN2UB), Barcelona, Spain"},{"name":"Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patric","family":"Turowski","sequence":"additional","affiliation":[{"name":"UCL Institute of Ophthalmology, University College of London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,5,6]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature20411"},{"key":"e_1_3_2_4_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/2525967","article-title":"Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications","volume":"2017","author":"Liu Z","year":"2017","unstructured":"Liu Z , ZhouT, ZieglerAC, DimitrionP, ZuoL. Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications. Oxid. Med. Cell Longev.2017, 1\u201311 (2017).","journal-title":"Oxid. Med. Cell Longev."},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2017.07.048"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30299-5"},{"key":"e_1_3_2_7_1","unstructured":"World Health Organization (WHO) (2019). www.who.int\/features\/qa\/55\/en\/"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30403-4"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30454-X"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30295-3"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30443-5"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30404-6"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/272630"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.01.024"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2016.07.007"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2011-110368"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2014.05.052"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12057"},{"issue":"6","key":"e_1_3_2_19_1","first-page":"2190","article-title":"The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid \u03b2 accumulation in mice","volume":"118","author":"Pickford F","year":"2008","unstructured":"Pickford F , MasliahE, BritschgiMet al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid \u03b2 accumulation in mice. J. Clin. Invest.118(6), 2190\u20132199 (2008).","journal-title":"J. Clin. Invest."},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxs013"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.100594"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029610"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq561"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.100859"},{"issue":"9","key":"e_1_3_2_25_1","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/nn.3786","article-title":"Alzheimer\u2019s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci","volume":"17","author":"De Jager PL","year":"2015","unstructured":"De Jager PL , SrivastavaG, LunnonK, BurgessJ, SchalkwykLC, YuL. Alzheimer\u2019s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat. Neurosci.17(9), 1156\u20131163 (2015).","journal-title":"Nat. Neurosci."},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2012.126"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00239"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24329"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.3109\/09687688.2014.937468"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2011.11.010"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.21"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61349-9"},{"issue":"64","key":"e_1_3_2_33_1","first-page":"1","article-title":"Advances in developing novel therapeutic strategies for Alzheimer\u2019s disease","volume":"13","author":"Cao J","year":"2018","unstructured":"Cao J , HouJ, PingJ, CaiD. Advances in developing novel therapeutic strategies for Alzheimer\u2019s disease. Mol. Neurodegen.13(64), 1\u201320 (2018).","journal-title":"Mol. Neurodegen."},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.7567"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2015.00054"},{"key":"e_1_3_2_36_1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-3-319-11776-8_38","volume-title":"5th International Conference on Biomedical Engineering in Vietnam","author":"Legname G","year":"2015","unstructured":"Legname G . Novel approaches to diagnosis and therapy in neurodegenerative diseases. Presented at: 5th International Conference on Biomedical Engineering in Vietnam. Ho Chi Minh, Vietnam, 155\u2013158 (2015)."},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.030205"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00728"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharma.2013.04.001"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2009.09.001"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1734-1140(12)70901-5"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.04.042"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(00)00339-4"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.progpolymsci.2011.01.001"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/238428"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.06.052"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2016.03.014"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics6040557"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.12.90"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2015.07.007"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2016.05.013"},{"issue":"2","key":"e_1_3_2_52_1","first-page":"749","article-title":"Systemic delivery to central nervous system by engineered PLGA nanoparticles","volume":"8","author":"Cai Q","year":"2016","unstructured":"Cai Q , WangL, DengG, LiuJ, ChenQ, ChenZ. Systemic delivery to central nervous system by engineered PLGA nanoparticles. Am. J. Transl. Res.8(2), 749\u2013764 (2016).","journal-title":"Am. J. Transl. Res."},{"key":"e_1_3_2_53_1","first-page":"1","article-title":"Multitargeted nanoparticles deliver synergistic drugs across the blood\u2013brain barrier to brain metastases of triple negative breast cancer cells and tumor-associated macrophages","volume":"1900543","author":"Zhang T","year":"2019","unstructured":"Zhang T , LipH, HeCet al. Multitargeted nanoparticles deliver synergistic drugs across the blood\u2013brain barrier to brain metastases of triple negative breast cancer cells and tumor-associated macrophages. Adv. Healthc. Mater.1900543, 1\u201315 (2019).","journal-title":"Adv. Healthc. Mater."},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.05.044"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2019.03.010"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.166"},{"key":"e_1_3_2_57_1","unstructured":"Prince PM PrinceM PrinceMet al. World Alzheimer Report 2016: improving healthcare for people living with dementia (2016). www.alz.co.uk\/research\/WorldAlzheimerReport2016.pdf"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2018.09.010"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2018.11.008"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2019.02.004"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2017.12.006"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2017.12.006"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2016.12.003"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.04.033"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2015.11.060"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2016.08.052"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.07.050"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2011.06.008"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2017.09.073"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2018.01.019"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2017.07.025"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2018.03.176"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2018.08.010"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2018.11.002"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.05.023"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2016.04.021"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118449"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2018.08.004"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2017.12.056"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2017.08.013"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.06.005"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.5607\/en.2014.23.3.246"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2013.07.042"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.7b06510"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201505413"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp3003946"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00281"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S164500"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2017.06.061"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.03.032"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.04.015"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.05.277"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1408686111"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2015.07.013"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2015.03.044"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.07.004"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.3892\/br.2016.630"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2011-110414"},{"issue":"737846","key":"e_1_3_2_99_1","first-page":"1","article-title":"The biphasic role of microglia in Alzheimer\u2019s disease","volume":"2012","author":"Mizuno T","year":"2012","unstructured":"Mizuno T . The biphasic role of microglia in Alzheimer\u2019s disease. Int. J. Alzheimers Dis.2012(737846), 1\u20139 (2012).","journal-title":"Int. J. Alzheimers Dis."},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.02.010"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00233"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2017.10.007"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2012.00138"},{"issue":"3","key":"e_1_3_2_104_1","first-page":"1","article-title":"Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer\u2019s disease","volume":"12","author":"Parbo P","year":"2020","unstructured":"Parbo P , MadsenLS, IsmailRet al. Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer\u2019s disease. Alzh. Res. Ther.12(3), 1\u20137 (2020).","journal-title":"Alzh. Res. Ther."},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900844"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S49923"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25410"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz165"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104707"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e318225038c"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8394-2"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-57193-5_12"},{"issue":"2","key":"e_1_3_2_113_1","first-page":"29","article-title":"The prevalence, incidence and etiology of epilepsy","volume":"2","author":"Ali N","year":"2014","unstructured":"Ali N , NabiM. The prevalence, incidence and etiology of epilepsy. Int. J. Clin. Exp. Neurol.2(2), 29\u201339 (2014).","journal-title":"Int. J. Clin. Exp. Neurol."},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61689-4"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2010.10.027"},{"key":"e_1_3_2_116_1","first-page":"42","article-title":"Antiepileptic drugs in development pipeline: a recent update","volume":"4","author":"Kaur H","year":"2016","unstructured":"Kaur H , KumarB, MedhiB. Antiepileptic drugs in development pipeline: a recent update. Neurol. Sci.4, 42\u201351 (2016).","journal-title":"Neurol. Sci."},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2015.12.013"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jobaz.2015.02.001"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2012.04.001"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2005.08.003"},{"key":"e_1_3_2_121_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2019.1620603"},{"key":"e_1_3_2_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtice.2018.03.028"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-181331"},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60111-1"},{"issue":"40","key":"e_1_3_2_125_1","first-page":"1","article-title":"Huntington\u2019s disease: a clinical review","volume":"5","author":"Roos RAC","year":"2010","unstructured":"Roos RAC . Huntington\u2019s disease: a clinical review. Orphanet J. Rare Dis.5(40), 1\u20138 (2010).","journal-title":"Orphanet J. Rare Dis."},{"key":"e_1_3_2_126_1","first-page":"180165","article-title":"Insights into GABA A ergic system alteration in Huntington\u2019s disease","volume":"8","author":"Hsu Y","year":"2018","unstructured":"Hsu Y , ChangY, ChernY. Insights into GABA A ergic system alteration in Huntington\u2019s disease. Royal Soc. Publish.8, 180165 (2018).","journal-title":"Royal Soc. Publish."},{"key":"e_1_3_2_127_1","doi-asserted-by":"publisher","DOI":"10.1159\/000443738"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.8655"},{"key":"e_1_3_2_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.12.003"},{"key":"e_1_3_2_130_1","doi-asserted-by":"publisher","DOI":"10.1021\/jp905580j"},{"key":"e_1_3_2_131_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm985"},{"key":"e_1_3_2_132_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.6b06853"},{"key":"e_1_3_2_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2017.12.005"},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-013-1080-3"},{"key":"e_1_3_2_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dhjo.2019.05.005"},{"key":"e_1_3_2_136_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0916-7"},{"key":"e_1_3_2_137_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612826666200116142922"},{"key":"e_1_3_2_138_1","unstructured":"Aphios . Study of APH-1105 in patients with mild to moderate Alzheimer\u2019s disease (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03806478"},{"key":"e_1_3_2_139_1","unstructured":"Rambam Health Care Campus . Exploratory study using nanotechnology to detect biomarkers of Parkinson\u2019s disease from exhaled breath (2012). https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT01246336?term=nanoparticle&cond=Parkinson+Disease&draw=2&rank=1"},{"key":"e_1_3_2_140_1","unstructured":"Clene Nanomedicine . 31P-MRS imaging to assess the effects of CNM-Au8 on impaired neuronal redox state in Parkinson\u2019s disease (REPAIR-PD) (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03815916?term=nanoparticle&cond=Parkinson+Disease&draw=2&rank=2"},{"key":"e_1_3_2_141_1","unstructured":"Clene Nanomedicine . 31P-MRS imaging to assess the effects of CNM-Au8 on impaired neuronal redox state in multiple sclerosis (REPAIR-MS) (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03993171?term=nanoparticle&cond=multiple+Sclerosis&draw=2&rank=3"},{"key":"e_1_3_2_142_1","unstructured":"National Institutes of Health Clinical Center . Invivo characterization of inflammation with ferumoxytol an ultrasmall superparamagnetic iron oxide nanoparticle on 7 Tesla magnetic resonance imaging (2019). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02511028?term=nanoparticle&cond=Multiple+Sclerosis&draw=2&rank=1"},{"issue":"3","key":"e_1_3_2_143_1","first-page":"16","article-title":"Different techniques for preparation of polymeric nanoparticles \u2013 a review","volume":"5","author":"Nagavarma BVN","year":"2012","unstructured":"Nagavarma BVN , YadavHKS, AyazA, VasudhaLS, ShivakumarHG. Different techniques for preparation of polymeric nanoparticles \u2013 a review. Asian J. Pharm. Clin. Res.5(3), 16\u201323 (2012).","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"e_1_3_2_144_1","first-page":"107","article-title":"Lipid nanoparticulate drug delivery systems: a revolution in dosage form design and development","author":"Attama AA","year":"2012","unstructured":"Attama AA , MomohMA, BuildersPF. Lipid nanoparticulate drug delivery systems: a revolution in dosage form design and development. Recent Adv. Nov. Drug. Carrier Syst.107\u2013140 (2012).","journal-title":"Recent Adv. Nov. Drug. Carrier Syst."},{"key":"e_1_3_2_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.08.033"}],"container-title":["Nanomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/nnm-2019-0443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:49:32Z","timestamp":1716493772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/nnm-2019-0443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":143,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.2217\/nnm-2019-0443"],"URL":"https:\/\/doi.org\/10.2217\/nnm-2019-0443","relation":{},"ISSN":["1743-5889","1748-6963"],"issn-type":[{"value":"1743-5889","type":"print"},{"value":"1748-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=innm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=innm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-12-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}